Mira Pharmaceuticals (MIRA) Common Equity (2022 - 2025)
Mira Pharmaceuticals (MIRA) recorded Common Equity of $10.4 million in the quarter ended Dec 31, 2025, up 372.7% from $2.2 million a year earlier and up 37.8% from the prior quarter.
Powered by 
Analysis
Mira Pharmaceuticals (MIRA) Common Equity (2022 - 2025) Analysis & Trends
Starting with the quarter ended Sep 30, 2022, Mira Pharmaceuticals' Common Equity history includes 14 quarters.
- Across earlier years, Common Equity came in at $2.2 million in the year ended Dec 31, 2024 (-49.7%), $4.37 million in the year ended Dec 31, 2023 and -$596,232 in the year ended Dec 31, 2022.
- The figure for the quarter ended Dec 31, 2025 is the highest quarterly Common Equity in data going back to the quarter ended Sep 30, 2022.
- On a year-over-year basis, Common Equity rose in three of the last seven quarters, with growth averaging 47.2%.
- Per Business Quant, the preceding three quarters came in at $7.55 million (quarter ended Sep 30, 2025), $569,859 (quarter ended Jun 30, 2025) and $1.29 million (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Mira Pharmaceuticals | 14.93 Mn | -5.58 Mn | - | 10.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 10.40 Mn |
| Sep 30, 2025 | 7.55 Mn |
| Jun 30, 2025 | 569,859.00 |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | 3.16 Mn |
| Dec 31, 2023 | 4.37 Mn |
| Sep 30, 2023 | 8.12 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | -1.79 Mn |
| Dec 31, 2022 | -596,232.00 |
| Sep 30, 2022 | 320,449.00 |
| Jun 30, 2022 | 1.08 Mn |
API Access
Mira Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MIRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MIRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MIRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();